Enhance Recovery. Optimize ICU Resource Utilization.
See how PleuraFlow® Active Clearance Technology® can help free ICU resources and get patients home faster.
Read more

About Us

We believe that there is nothing more beautiful than getting patients back home to their lives and their loved ones faster.

Recovery is Beautiful®

The Team

Leadership

Paul Molloy

CEO

Paul Molloy, ClearFlow’s CEO has participated in two successful IPO’s (one he led as CEO in 2005 & exited three of his last four firms as CEO and participated in exits at the Board level in several other MedTech firms in the last decade (including NASDAQ listed CASMed to Edwards Life Sciences and Revolutionary Medical Devices to Vyair). He is presently on the Board at ClearFlow, Inc. and Augustine Medical (a temperature management company founded by Scott Augustine, founder of Bair Hugger FAW). He managed Teleflex’s largest division (Arrow Vascular) from 2011-2013 with a $700M P&L, six US and international manufacturing plants employing over 3,000 staff and a US sales organization of 100 reps. Significant value creation (TFX, NYSE) resulted during this tenure (publicly available filings). Paul was a CRNA in clinical practice, earned a diploma in Hospital Management from the Instituut Der Bedrijfswetenschappen in The Netherlands and holds an MBA from University of Chicago Booth School of Business.

Ed Boyle

Founder and Chairman

Dr. Edward Boyle (Founder) is a cardiothoracic surgeon and founder of ClearFlow, Inc. Dr. Boyle has published over 75 manuscripts in peer reviewed medical journals and textbooks. In addition to obtaining NIH funding, he played a lead role in developing research collaborations with Bayer’s Pharmaceutical Division, Genentech, Zymogenetics/Novo Nordisk, Icos Corporation, US Surgical Corporation (now Covidien) and other privately held biotechnology and device companies. His research has been recognized nationally with awards from the American College of Surgeons, the American Heart Association, The Western Thoracic Surgery Association, the Seattle Surgical Society and others. He has extensive clinical and medical device expertise and has guided the Company’s clinical evidence and study strategy. Through background and training, his experience aligns perfectly with the target company devices and their indications for use and benefits.

Serrah Namini

Vice President RA, CA, QA

Serrah Namini, Vice President of Regulatory, Quality and Clinical Affairs is a double-engineer (Biomedical & Electrical) by degree and her extensive experience includes ten years with the FDA as Consumer Safety Officer and Pacific Region Team Leader for Radiological Health team as well as four years working with Notified Bodies including Intertek. She has led global regulatory and quality departments and consulted for FDA regulated companies including startup, medium and large multi-site companies. She has worked for ClearFlow for three years as the VP of Regulatory, Clinical & Quality Affairs and has maintained “clean-sheet” compliance and excellence in a Lean-Six-Sigma Quality environment. Under her leadership the company has maintained Good Standing with all US, International and EU auditing bodies under the Company’s cloud based ISO13485 Quality System, which allows ClearFlow to present new and modified devices rapidly within its Quality Management system to international and US market clearance. Under Serrah’s leadership, ClearFlow has achieved numerous 510(K) market clearances, CE Mark to the new European regulations and multiple RoW market clearances.

James Herlofsky

Director of Clinical Training

James Herlofsky M.D., Director of Clinical Training and Education and is responsible for the development, implementation, and management of training programs for both the ClearFlow Sales Organization as well as Healthcare Professionals in the field. Dr. Herlofsky has been with ClearFlow for over 5 years and has demonstrated excellent project management and leadership skills while working cross-functionally with Direct and Distributor Sales channels, Marketing, Clinical Specialists, Regulatory and R&D and Engineering departments in sustaining engineering efforts and new product development. Dr. Herlofsky played a key role in the development and integration of ClearFlow’s Product Implementation Process to initiate and maintain utilization within hospitals more effectively. More recently, he led the development of ClearFlow’s mobile clinical support app, the ClearFlow Assistant. Fluent in both Spanish and English, Dr. Herlofsky has spearheaded several international clinical and sales training sessions. Dr. Herlofsky has worked with Key Opinion Leaders from some of the world’s most prestigious cardiac surgery centers (Cleveland Clinic, Mayo Clinic, Montreal Heart Institute) and brings a wealth of experience ranging from clinical knowledge, training and education to management and leadership.

Tony Mathiason

U.S. Sales Director

Tony Mathiason, Director of Sales USA, brings 30 years of medical sales experience to the ClearFlow commercial team, the last 20 years of which within the Cardiovascular space. His experience includes 2 years selling the Research Medical (RMI) line of Perfusion cannulae and CO2 Laser for TMLR, consistently meeting and exceeding sales goals while managing the largest territory for the Division. Following this, Tony focused his sales career on emerging cardiovascular technologies, including AtriCure, On-X Life Technologies and nContact, Inc. Tony’s exceptional cardiac surgery commerce credentials serve him perfectly as US Director of Sales at ClearFlow. His broad sales background and management of both Direct and Distributor sales channels and clinical specialist teams arm him with the capability and know-how to move a product from infancy of use to broad market acceptance and sustain and nurture critical KoL relationships. Tony has spent his entire medical career based in Houston, Texas and holds a Bachelor of Arts Degree from the University of Houston.

Ken Chesnin

Director of R&D and Engineering

Ken Chesnin, Vice President of Engineering and Operations has more than twenty years of experience in product development and manufacturing of medical devices, in particular catheters. Prior to ClearFlow, he was Director of Sensor Development at GluMetrics, Inc., a venture backed company that developed a novel catheter-based sensor for real-time intravascular measurement of glucose. Previously he led an engineering team at Medical Components, Inc. that developed and commercialized FDA class II and III vascular devices. He also led an engineering team at Martech Medical, a contract manufacturer that supplies components and finished devices to medical device companies. He holds degrees in Mechanical and Biomedical Engineering. His experience spans concept to commercialization; including design, process development, validation, and manufacturing. Ken is an inventor on ten issued US utility patents. He has worked at ClearFlow for eight years and oversees all R&D, sustaining engineering, and supply chain.

Hannah Beathard

Vice President of Finance

Hannah Beathard, CPA, Vice President of Finance, joined ClearFlow over four years ago from PricewaterhouseCoopers (PwC) where she gained extensive experience in the assurance practice servicing clients from a wide array of industries, ranging from healthcare to large cap manufacturing companies, both in the private and publicly traded spheres. Hannah oversees all areas of Finance & Accounting at ClearFlow and has focused on implementing cutting-edge technology solutions and lean-work disciplines to ensure capital efficiency, while maintaining first-class management reporting and compliance. Other areas of expertise include organizational restructuring, cap table management, financial modeling, forecasting, and budgeting. She has been materially involved in numerous debt & equity capital raises for the Company and regularly participates in vital business development work, presenting to venture capital firms, private equity firms and public corporations. Hannah holds an active certified public accountant license in the state of California and earned degrees in both Finance & Accounting, summa cum laude, from the University of Delaware. Under her leadership, ClearFlow has received all unqualified financial statement audit opinions.

Board of Directors

Ed Boyle

Founder and Chairman

Dr. Edward Boyle (Founder) is a cardiothoracic surgeon and founder of ClearFlow, Inc. Dr. Boyle has published over 75 manuscripts in peer reviewed medical journals and textbooks. In addition to obtaining NIH funding, he played a lead role in developing research collaborations with Bayer’s Pharmaceutical Division, Genentech, Zymogenetics/Novo Nordisk, Icos Corporation, US Surgical Corporation (now Covidien) and other privately held biotechnology and device companies. His research has been recognized nationally with awards from the American College of Surgeons, the American Heart Association, The Western Thoracic Surgery Association, the Seattle Surgical Society and others. He has extensive clinical and medical device expertise and has guided the Company’s clinical evidence and study strategy. Through background and training, his experience aligns perfectly with the target company devices and their indications for use and benefits.

Paul Molloy

CEO

Paul Molloy, ClearFlow’s CEO has participated in two successful IPO’s (one he led as CEO in 2005 & exited three of his last four firms as CEO and participated in exits at the Board level in several other MedTech firms in the last decade (including NASDAQ listed CASMed to Edwards Life Sciences and Revolutionary Medical Devices to Vyair). He is presently on the Board at ClearFlow, Inc. and Augustine Medical (a temperature management company founded by Scott Augustine, founder of Bair Hugger FAW). He managed Teleflex’s largest division (Arrow Vascular) from 2011-2013 with a $700M P&L, six US and international manufacturing plants employing over 3,000 staff and a US sales organization of 100 reps. Significant value creation (TFX, NYSE) resulted during this tenure (publicly available filings). Paul was a CRNA in clinical practice, earned a diploma in Hospital Management from the Instituut Der Bedrijfswetenschappen in The Netherlands and holds an MBA from University of Chicago Booth School of Business.

Alexander Suh

Founding Managing Director, California Technology Ventures

Alex Suh is a founding Managing Director with California Technology Ventures, LLC, a Southern California venture capital firm that focuses its investments in the fields of Life Sciences and Information Technology.

Alex is also a founding Managing Director with J.J. Jacobs Enterprises, LLC and Jacobs Capital Group, LLC, both Pasadena-based venture capital and fund-of-fund firms where he has invested in other venture capital funds globally that offer a strategic fit with California Technology Ventures.

Alex was an entrepreneur starting several businesses, helped develop the first small business incubator in the San Gabriel Valley, managed several small business lending programs, consulted with nonprofits and cities on economic development projects and taught college in entrepreneurship, business and management.

Alex currently or formerly sat on the advisory board for EmTek, a San Diego based community small business lending and equity program; LARTA, a technology think tank; Claremont Graduate University’s Venture Financial Institute; and the Life Science Steering committee for State of California Governor’s Policy Office, Advisory Board member City of Hope’s International Translational & Regenerative Medicine Center (ITRC), SoCalBio (SCBC) Advisory Board member, and Member of Board of Trustees and Advisory Council member for Keck Graduate Institute of Applied Life Sciences.

His community involvement included past chairman to Villa Esperanza, a school for developmentally challenged persons; distinguished president for Kiwanis; Advisory board member for Women at Work and the Crippled Children’s Society; Special Olympics coach, ocean advocate and others.

Alex was honored in 2009, Outstanding 50 Asian Americans in Business while California Technology Ventures was also named by ACQ Finance Magazine’s Technology Investor of the Year, North America, 2010.

Ned Scheetz

Managing Director, Aphelion Capital

Mr. Scheetz founded Aphelion Capital, LLC in 2005. Prior to forming Aphelion, Mr. Scheetz was a partner and managing director with Piper Jaffray Ventures (PJV) for nearly eight years, focusing on investments in emerging medical technology companies. Mr. Scheetz joined PJV from Janus Capital, where he was a senior research analyst covering medical technology. Before beginning his investment career Mr. Scheetz worked in various product management roles with a subsidiary of Eastman Kodak and in sales with Kraft General Foods.

Mr. Scheetz is a graduate of Colby College, Duke University’s Fuqua School of Business, and was a post-graduate scholar at Oxford University. Mr. Scheetz holds the CFA designation, and is a board member of ClearFlow, Curant, and OrthAlign. Mr. Scheetz is an advisory board member with the Center for Medical Device Innovation, and on the business advisory board of The Epilepsy Therapy Development Project.

Chris Martin

President, Medical Devices & Chief Financial Officer, Research Corporation Technologies

Along with his responsibilities as CFO, Martin is President, Medical Devices, treasurer and a director of the RCT board of directors. He leads the RCT team focused on medical device investments. Martin holds an M.B.A. in finance/strategy from The Anderson School, UCLA, an M.S. in biomedical engineering from the University of Southern California, and a B.S. in biology/biochemistry from the University of Michigan.

Marc Croijmans

Director, ClearFlow BV, The Netherlands

Marc Croijmans, Director of ClearFlow B.V. in the Netherlands, brings 30 years of European sales and business development to ClearFlow. Prior to joining ClearFlow B.V., Marc was co-owner and CEO for an international recruitment & US visa Support Company with offices in Maastricht (NL) and Atlanta (USA) and area manager for a Dutch staffing company. Marc joined ClearFlow at the inception of the Dutch entity, overseeing all European distribution and financial activities.

Next to his position at ClearFlow B.V., he acts as an Executive Consultant and Interim Manager for his own company ME Consultancy. Marc has specialized in assisting organizations in realizing all aspects of setting up business with a strong focus on site selection, international marketing, human resources and business development within Europe and the USA. Marc joined the Houston based TMC-x Advisor and Mentor Program as international business development advisor. He holds a Bachelor’s degree in Business and Economics at the Maastricht University of Applied Sciences and is fluent in four languages.